NDA/BLA Approval Totals: Will US FDA Recover From Slow Start Again?

 
• By Derrick Gingery
  
slowdown
Average NDA/BLA approvals per month is lower than years past through the first third of calendar year 2023. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews